1 3 2 1 a r t I C l e S Neuron-lineage and subtype-specific transcription factors play a critical role in the differentiation and functional specification of neurons during brain development 1,2 and in the adult brain 3 . The transcriptionfactor-driven enforcement of neuronal specification overlaps with the suppression of genes that, in their own right, can drive differentiation of non-neuronal cells or neurons of other types. Much of the negative gene regulation in developing neurons is achieved by PRC2 (ref. 4). The function of PRC2 is mediated by its enzymatic components, Ezh1 and Ezh2, which catalyze histone H3 Lys27 di-and trimethylation (H3K27me2 and H3K27me3) 5,6 . PRC2-mediated H3K27me3 leads to gene silencing 6 , which is consistent with the role of PRC2 in preventing the expression of non-neuronal genes in developing neurons 4 .
to neuronal metabolic activity 9 . Additionally, neuronal activation can lead to the phosphorylation of histone H3 at Ser28 (H3S28) followed by the dissociation of PRC2 from chromatin and an ensuing loss of H3K27me3 (ref. 10) . Changes in PRC2 activity and alterations in H3K27me3 levels and distribution have recently been implicated in several human neurodegenerative diseases 11, 12 , including Huntington's disease (HD) 13, 14 . Recent studies have identified PRC2 as a direct target of the huntingtin protein 13 . Moreover, the expression of mutant huntingtin in mouse embryonic stem (ES) cells or neuronal progenitor cells alters the pattern of genome-wide H3K27me3 distribution in both cell types 15 . The possible link between PRC2 and HD is further supported by the loss of neuronal PRC2 H3K27me3 sites 14 and the upregulation of some PRC2 target genes in the HD-affected human brain 14, 16, 17 . While these studies suggest that PRC2 might represent a common target of different pathological processes that drive neurodegenerative diseases, the role of PRC2 in the regulation of neuronal specification, function and survival in the adult brain is not known.
To address the significance of PRC2 in adult neurons in vivo, we generated mice with a PRC2 deficiency in highly specialized medium spiny neurons (MSNs) in the striatum. We found that PRC2 was essential for MSN-specific gene expression and function. The deficiency in PRC2 directly affected a selected group of PRC2 target genes that encode transcription factors normally suppressed in MSNs, as well as death-promoting proteins. The ectopic expression of non-MSN and non-neuronal lineage specific transcription factors in PRC2deficient MSNs was associated with a downregulation of genes that are 1 3 2 2 VOLUME 19 | NUMBER 10 | OCTOBER 2016 nature neurOSCIenCe a r t I C l e S required for MSN-specific functions. These collective changes in gene expression were accompanied by altered neuronal physiology and the development of progressive and fatal neurodegeneration.
RESULTS

Conditional inactivation of PRC2 in adult neurons
The PRC2 deficiency in MSNs was achieved by combining a null mutation in the Ezh1 gene (Ezh1 −/− ) with conditional ablation of the Ezh2 gene in different types of neurons (Supplementary Fig. 1a) . To achieve the forebrain neuron-specific Ezh2 gene inactivation, we combined loxP-flanked Ezh2 (Ezh2 fl/fl ) 18 and Camk2a-cre alleles in Ezh2 fl/fl ;Camk2a-cre mice, which allows Cre-mediated recombination of loxP-modified genes in projection neurons in the striatum, cortex and hippocampus at 2 weeks of age. Neuronal development and maturation are associated with a switch from predominantly Ezh2-containing to mostly Ezh1-containing PRC2 (Fig. 1a) . However, neither Ezh1 nor Ezh2 deficiency alone (Supplementary Fig. 1b ) affected the overall levels or the genome-wide distribution of H3K27me3 (Fig. 1b,c) , and only the combined Ezh1 and Ezh2 deficiencies led to a loss of H3K27me3 in MSNs in the striatum ( Fig. 1b-d) . The global loss of H3K27me3 in the MSNs became evident around 6 weeks of age and approximately 3-4 weeks after PRC2 inactivation ( Fig. 1d) . As expected, the H3K27me3 deficiency in Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice was strictly neuron-specific. The glia cells from these mice expressed wild-type levels of H3K27me3 (Fig. 1d) .
The delayed ablation of H3K27me3 in MSNs with respect to the timing of PRC2 inactivation suggests that most of the postnatal MSN development in Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice occurred in the presence of wild-type-like H3K27me3 levels. This finding argues against a possible developmental impact of PRC2 deficiency on adult MSN gene expression in Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice.
To inactivate PRC2 specifically in specialized adult neurons, we limited PRC2 inactivation to specific neuron types. In particular, we generated mice with PRC2 selectively inactivated in neurons expressing dopamine D1 or D2 receptors. This was achieved by breeding Drd1a-cre or Drd2-cre mice to the Ezh1 −/− ;Ezh2 fl/fl mice (Supplementary Fig. 1a ). To exclude any potential developmental impacts of PRC2 ablation, we used an adeno-associated virus (AAV)-based approach to inactivate PRC2 in the striata of 10-week-old Ezh1 −/− ;Ezh2 fl/fl mice (Supplementary Fig. 1a ). Finally, we used the Purkinje-cell-specific Cre-expressing mouse strain Pcp2-cre to inactivate PRC2 in postnatal cerebellar Purkinje cells (Supplementary Fig. 1a ). Details of the neuron-type-specific PRC2 inactivation are discussed below in the context of the cell-type-specific impact of PRC2 deficiency on gene expression and cell function.
PRC2 targets non-neuronal, non-MSN and death-promoting genes in adult MSNs
To elucidate the role of PRC2 in regulating neuronal cell-typespecific gene expression, we first identified the PRC2 target genes in MSNs of adult mice. To address the chromatin state of genes in MSNs, we conducted our studies on highly purified, ex vivo-isolated MSN nuclei (Supplementary Fig. 2a) . We found that genes associated with H3K27me3 in adult MSNs were transcriptionally silent and lacked RNA polymerase II or the activation-associated histone H3 Lys27 acetylation (H3K27ac) at the transcriptional start sites (TSS; Fig. 2a,b) . The majority of the H3K27me3-enriched genes include genes that are normally expressed either in cells of non-neuronal lineages or in non-MSN neurons ( Fig. 2c) .
A large fraction of H3K27me3-enriched (fragments per kilobase per million mapped reads, or FPKM, > 1.2; Supplementary Table 1 ) and transcriptionally silent genes in MSNs possess H3K4me3 at their TSS, which is commonly associated with transcriptional activity 19 ( Fig. 2b,d,e and Supplementary Table 2 ). The simultaneous presence of H3K27me3 and H3K4me3, which is defined as chromatin bivalency 20, 21 , has been validated by the sequential immunoprecipitation of H3K27me3-associated chromatin from ex vivo-isolated adult MSNs followed by H3K4me3 immunoprecipitation (Fig. 2f) . Approximately 65% (544 of 835, P < 0.0001) of the bivalent genes in MSNs overlapped with genes previously identified as bivalent in ES cells 21, 22 , while the rest of the bivalent genes were MSN-specific ( Supplementary Fig. 2b) .
The most abundant class of bivalent loci in MSNs was represented by genes that encode transcriptional regulators associated with non-MSNs, as well as with non-neuronal cells ( Fig. 2g) . Notably, the MSN bivalent genes included genes that encode important regulators of cell death ( Fig. 2g) , such as Pmaip1 (also called Noxa), Bik, Cdkn2a and Cdkn2b, Trp73, Gas1, Wt1 and Ccnd1 (Supplementary Table 2 ).
Selective PRC2 target gene upregulation in the absence of PRC2 PRC2 targets thousands of genes in adult MSNs ( Fig. 2a ). However, PRC2 deficiency leads to highly selective changes in MSN gene expression that occur with a substantial delay after the onset of Fig. 3a) , we observed upregulation of PRC2 target genes at 3 months of age ( Fig. 3a) . By 6 months of age, we observed an increase in both the number ( Fig. 3a) and expression levels ( Fig. 3b ) of upregulated genes in MSNs. The majority of upregulated genes were direct targets of H3K27me3 ( Fig. 3b and Supplementary Fig. 3a) , and more than 50% displayed a bivalent chromatin state in wild-type MSNs ( Fig. 3b and Supplementary Table 3 ). These data suggest that PRC2 plays a specific role in the suppression of bivalent genes in MSNs but does not explain the selectivity and time-dependent upregulation of PRC2 target genes.
The upregulated genes were greatly enriched for genes encoding non-MSN-expressed transcriptional regulators ( Fig. 3c,  Supplementary Fig. 3a and Supplementary Table 4 ), which were expressed at levels sufficient for detection by in situ hybridization in the mutant neurons (Fig. 3d) . The majority of the induced transcriptional regulators encoded homeobox genes, including numerous Hox genes ( Fig. 3e) , that are normally silenced in MSNs during early developmental stages.
The transcriptional control of more than 25% of the transcriptional regulators that become upregulated in the absence of PRC2 entails the formation of positive auto-regulatory feedback loops, as described in Ebf3
Lmx1b Lbx1
Foxl2 Foxl2os Table 5 ) or as identified by analysis of cis-regulatory elements (oPPOSUM and GENOMATIX analysis; Fig. 3e and Supplementary Table 5 ). A large fraction of the transcriptional regulators that become upregulated in PRC2-deficient MSNs have experimentally verified ( Fig. 3e and Supplementary Fig. 3b ) or sequence-predicted (Supplementary Table 5 ) co-regulatory functions that may allow the formation of transcriptional networks reinforcing the expression of these genes. Our data suggest that while the majority of H3K27me3 target genes in MSNs are notably insensitive to PRC2 deficiency, a selective group of predominantly bivalent PRC2 targets become expressed at relatively high levels as a result of their ability to form mutually reinforcing transcriptional networks. The formation of self-controlled, mutually reinforced transcription loops among PRC2 target genes represents a possible mechanism for the selective and progressive upregulation of PRC2 target genes in neurons.
PRC2 deficiency is associated with a downregulation of MSN-specific genes
The ectopic expression of PRC2 target genes in MSNs was associated with a concurrent downregulation of 119 MSN-expressed genes in Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice ( Fig. 3a and Supplementary Fig. 4a ).
The downregulated genes were not associated with H3K27me3 in wild-type MSNs and hence cannot be directly regulated by the PRC2 (Supplementary Fig. 4b ). The downregulated genes were significantly enriched (38 of 119, P < 0.0001, odds ratio: 25.16) for key regulators of MSN identity and specialized functions 23, 24 (Fig. 4a-c and Supplementary Table 6 ). PRC2-deficient MSNs displayed reduced expression levels of genes that encode important regulators of MSNspecific functions (Fig. 4a) , including neurotransmitter receptors (Drd2, Drd1a, Adora2a), signaling proteins (Arpp21, Rgs9, Pde10a), and MSN-specific transcription factors (Rxrg, Foxp1; Fig. 4b ). Many of the downregulated genes have been linked to neurological disease processes in humans ( Supplementary Fig. 4c ). The reduced expression of selected MSN genes was highly specific and was in contrast to the wild-type-like expression levels of the majority of MSN-expressed genes (Fig. 4c) . PRC2-deficient D2-receptor-expressing MSNs, while present at wild-type numbers in the striata of 5-month-old mutant mice, expressed significantly lower levels of the D2 MSN-specific gene Drd2 as compared to control D2 MSNs (Fig. 4d) .
On the basis of the known pattern of Camk2a expression in neurons, the conditional PRC2 deficiency may affect not only MSNs but also other forebrain projection neurons, including layer 5/6 cortical neurons, which directly innervate MSNs 25 . It is therefore conceivable that the downregulation of MSN-specific genes could reflect changes in their cortical innervation. To address this possibility, we used mice with D1-or D2-neuron-specific PRC2 inactivation. Ezh1 −/− ; Ezh2 fl/fl ;Drd1-cre or Ezh1 −/− ;Ezh2 fl/fl ;Drd2-cre mice were bred to Drd1-TRAP or Drd2-TRAP mice (Supplementary Fig. 5a ) for D1or D2-neuron-specific ribosome-associated mRNA analysis 23 . D1 or D2 MSN-specific PRC2 deficiency led to upregulation of the same PRC2 target genes, as well as a downregulation of MSN specific genes that we observed in the MSNs of Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice (Supplementary Fig. 5a ). These findings support the MSNcell-intrinsic nature of transcriptional changes that follow PRC2 Fig. 5b) . The PRC2 deficiency induced in adult MSNs was associated with changes in MSN gene expression similar to the changes observed in Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice or in PRC2-deficient D1 or D2 neurons (Supplementary Fig. 5a,c) .
PRC2 silences death-promoting genes
One of the distinct classes of PRC2 target genes in the MSNs of wildtype mice is represented by death-promoting genes (Fig. 2g) . We found that PRC2 deficiency in MSNs led to an upregulation of PRC2 target genes, such as Pmaip1, Bid, Igfbp3, and Cdkn2a and Cdkn2b (Fig. 5a) , that have a well-known role in the control of cell survival by promoting cell death 26 . Moreover, we observed an increased expression of the direct PRC2 target genes Ccnd1, which can trigger neuronal death in vitro 27 and has been implicated in several neurodegenerative processes 28 , and Wt1, a mediator of neuronal degeneration associated with Alzheimer's disease 29 (Fig. 5a) . The PRC2-dependent death-promoting genes were also upregulated in PRC2-deficient D1 or D2 neurons (Supplementary Fig. 6 ) and in adult striatal neurons following AAV-cre-mediated PRC2 inactivation (Supplementary Fig. 6 ).
PRC2 deficiency in MSN causes a progressive and fatal neurodegenerative phenotype
Concomitantly with the increased expression of death-promoting genes, the PRC2-deficient MSNs in 6-month-old Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice displayed a significant increase in γH2ax (Fig. 5b,c) . γH2ax is a marker of DNA double strand breaks and DNA damage linked to neurodegeneration in mice and in humans [30] [31] [32] . Moreover, electron microscopy analysis revealed multiple abnormal MSNs that displayed nuclear and cytoplasmic condensation in the presence of intact subcellular organelles (Fig. 5d) . This phenotype, which is known as dark cell degeneration, is a hallmark of neurodegeneration 33 . The cellular alterations of PRC2-deficient MSNs were accompanied by a significant reduction in both the total brain mass ( Fig. 5e ) and the number of MSNs (Fig. 5e ) in the striatum of the mutant mice. The downregulation of MSN-specific genes, the upregulation of the death-promoting PRC2 target genes and the morphological signs of neurodegeneration were intertwined with alterations in MSN physiology ( Fig. 6) . PRC2-deficient MSNs displayed enhanced intrinsic excitability with a significant increase in evoked action potential firing (Fig. 6a) , reduced firing threshold (reduced rheobase; Fig. 6b ) and increased input resistance (Fig. 6c) .
The described changes in PRC2-deficient MSNs were associated with altered behavior. Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice developed a fatal neurodegenerative condition characterized by progressively attenuated motor activity and balance. The altered motor functions were associated with impaired rotarod performance ( Fig. 6d) , impaired ability to hang on a wire top (Supplementary Fig. 7a ) and hind limb clasping behavior (Fig. 6e) , followed by a complete cessation of voluntary motor activity including feeding and drinking behavior in the home cage (Supplementary Fig. 7b ). These changes resulted in the premature death of mice around 6.5-7 months of age (Fig. 6f) .
It is possible that some aspects of the observed behavioral changes in Ezh1 −/− ;Ezh2 fl/fl ;Camk2a-cre mice reflect alterations in cortical neurons rather than MSN-autonomous changes. In support of the cell-autonomous role of PRC2 in the regulation of MSN function, we found that the virus-mediated loss of PRC2 specifically in adult striatal neurons led to a progressive impairment in motor behavior (Fig. 6g,h) . Moreover, the loss of PRC2 in both D1 and D2 neurons was associated with the premature death of the mutant mice (Fig. 6i) . These data support a MSN-autonomous role for PRC2 in the regulation of MSN function.
PRC2 controls Purkinje cell-specific gene expression and survival
The neurodegeneration caused by PRC2 deficiency is not uniquely restricted to neurons in the forebrain. The loss of PRC2 in postnatal a r t I C l e S cerebellar Purkinje cells (PCs) impaired the PC phenotype (Fig. 7) . Alterations in gene expression in PRC2-deficient PCs followed a pattern of gene expression changes similar to that observed in PRC2-deficient MSNs (Fig. 7b) . PC-specific translating ribosome affinity purification (TRAP) analysis of Ezh1 −/− ; Ezh2 fl/fl ;Pcp2-cre;Pcp2-TRAP mice revealed that PRC2-deficient PCs upregulated PRC2 target genes. Many of these genes included the same transcriptional regulators that were upregulated in PRC2-deficient MSNs (Fig. 7b) . As in PRC2-deficient MSNs, the de-repression of the PRC2 target genes was associated with downregulation of genes that are critical for PC function and survival ( Fig. 7b) . The reduced expression of genes controlling PC function and survival may augment the effect of potential death-promoting PRC2 target genes that were upregulated in PRC2-deficient PCs (Fig. 7b) . As in PRC2-deficient MSNs, the changes in PC-specific gene expression were associated with a progressive loss of PCs and an accompanying impairment in motor behaviors (Fig. 7a,c,d) .
We observed a significant, age-dependent decrease in the size of the molecular layer (Fig. 7d) followed by a significant reduction in the number of PC bodies at 9 months of age (Fig. 7d) . These data support the general relevance of the PRC2 in the maintenance of adult neuron function and survival. npg a r t I C l e S DISCUSSION PRC2-mediated H3K27me3 is one of the hallmarks of developmentally determined gene silencing that contributes critically to the differentiation of various cell types 6, 34 . Our studies addressed the role of PRC2 in adult neurons where neuronal lineage specification is associated with highly specialized neuron type-specific gene expression programs 23, 35 . We showed that the maintenance of H3K27me3 in adult neurons requires the presence of either Ezh1 or Ezh2, which represent homologous but structurally distinct enzymatic components of PRC2 (ref. 5). Although Ezh2 expression levels decline sharply during early postnatal brain development 7 , this enzyme can compensate for a deficiency in Ezh1, which dominates PRC2 in adult neurons (Fig. 1a) . The redundancy between Ezh1 and Ezh2 may reflect specific features of postmitotic neurons since Ezh1 cannot substitute for Ezh2 in dividing cells during brain development 6 .
In MSNs, H3K27me3 remains at wild-type levels for at least 2 weeks after PRC2 ablation. The stability of H3K27me3 in neurons does not reflect the existence of another, as-yet-unidentified H3K27me3-specific histone methyltransferase, as the combined deficiency in Ezh1 and Ezh2 ultimately leads to H3K27me3 loss. The durability of H3K27me3 in the absence of PRC2 cannot be attributed to the lack of expression of H3K27me3-specific demethylases Jmjd3 and Utx. Both enzymes are expressed at wild-type levels in PRC2deficient MSNs (data not shown). In the most likely scenario, the stability of H3K27me3 reflects the low rate of histone H3 turnover in nondividing cells, including neurons 36, 37 , in combination with the slow kinetics of lysine demethylation by Jmjd3 and Utx 38 .
We identified 2,057 PRC2 target genes in MSNs, which are associated with high levels of H3K27me3 at their TSS. Many of these PRC2 targeted genes (835 of 2,057) are associated with H3K27me3 and H3K4me3 bivalent chromatin. In ES cells as well as in cells of other types, chromatin bivalency supports the plasticity of cell differentiation [39] [40] [41] . However, it is unlikely that fully differentiated MSNs could benefit from the expression of genes that can potentially alter MSN differentiation and function. It is possible that the bivalent state of these transcriptional regulators is a reflection of their specific DNA The indicated gene expression levels were measured using TRAP PC-specific mRNA analysis of cerebella derived from Ezh1 −/− ;Ezh2 fl/fl ;Pcp2-cre;Pcp2-TRAP mice or control mice (n = 3 mice each (2 males, 1 female). Left: Barx1: P = 0.026, t 4 = 3.451; Foxa1: P = 0.0229, t 4 = 3.592; Foxd1: P = 0.0113, t 2 = 9.336; Hand2: P = 0.0252, t 2 = 6.185; Pitx2: P = 0.0085, t 4 = 4.818; Pou4f1: P = 0.0034, t 4 = 6.205; Sfmbt2: P = 0.0036, t 4 = 6.119; Tal1: P = 0.006, t 4 = 5.325; Zic2: P = 0.0009, t 4 = 8.888. Center: Bid: P = 0.0267, t 4 = 3.425; Cdkn2b: P = 0.0401, t 4 = 2.995; Ccnd1: P < 0.0001, t 4 = 20.12; Gata4: P = 0.0096, t 4 = 10.12; Hoxa5: P = 0.0054, t 4 = 5.488; Trp73: P = 0.0032, t 4 = 6.342. Right: Calb: P = 0.0165, t 4 = 3.976; Ebf3: P = 0.0233, t 2 = 6.438; Fxn: P = 0.0073, t 4 = 5.037; Lhx1: P = 0.0012, t 4 = 8.273; Lhx5: P = 0.0409, t 4 = 4.792; Pcp2: P = 0.0401, t 2 = 4.845; Pvalb: P = 0.0022, t 4 = 6.954; Rora: P = 0.0026, t 4 = 6.696). (c) Progressive loss of motor coordination and balance was determined by rotarod tests (top; n = 4 control mice (3 males, 1 female), 9 mutant mice (5 males, 4 females); interaction: P = 0.0002, F 1,11 = 3.626; genotype: P < 0.0001, F 1,11 = 50.82) and footprint assays (bottom; n = 6 mice each (3 males, 3 females), two trials; representative image is shown; scale bar, 1 cm). (d) A decrease in average lobe diameter over time (left, n = 5 brain sections; P < 0.0001, F 2,12 = 121.2) and the number of PC as determined by Nissl staining (right, n = 3 mice (16 control, 18 mutant brain slides; P < 0.0001, t 32 = 8.541) are shown. Data are mean ± s.e.m.; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 from two-tailed Student's t-test with Welch's correction or two-way ANOVA with repeated measures. a r t I C l e S sequence. A majority of bivalent promoters contain CpG islands 40 , and PRC2 is commonly recruited to (G+C)-rich sequence elements 42, 43 .
TSS-associated H3K4me3 is not only an indicator of a gene's transcriptional potential but can also be a marker of promoter-associated transcription. In turn, it has been shown that transcription can promote PRC2 recruitment 44 . Therefore, it is possible that the presence of H3K4me3 is required for PRC2 recruitment and subsequent gene silencing. One can envision a scenario in which the presence of H3K4me3 on bivalent genes may support low levels of transcriptional activity; such a scenario could entail promoter-associated transcription, which may not yield the full-length RNA but remains necessary and sufficient for the recruitment and/or maintenance of the PRC2 required for gene silencing.
Our data suggest that the function of PRC2 in adult neurons lies in the transcriptional suppression of bivalent genes, while the majority of H3K27me3-associated gene suppression does not depend on PRC2 activity. The necessity of PRC2 for bivalent gene silencing in adult neurons is consistent with a similar role of PRC2 in adult mouse intestine, blood and skin cells, where PRC2 controls the tissue-specific gene expression patterns via bivalent gene suppression 45 .
PRC2 deficiency in MSNs leads to a surprisingly delayed (with respect to the timing of the onset of H3K27me3 deficiency) upregulation of a limited group of bivalent PRC2 targets that are enriched for genes encoding other cell-or neuron-type-specific transcriptional regulators. These selective changes in gene expression may reflect the ability of many of the upregulated transcription factors to form autoor co-regulatory transcriptional networks. It is possible that loss of H3K27me3 and the ensuing acquisition of H3K27ac may lead to a transcriptionally promiscuous state of a large number of PRC2 targets. However, only those that can form auto-or co-regulatory networks will reach detectable RNA expression levels over time. The selective upregulation of genes in PRC2-deficient cells may therefore reflect not only the role of H3K27me3 in transcriptional silencing but also the specific transcriptional features of the de-repressed PRC2 gene targets. Our data suggest that the selectively upregulated H3K27me3 target genes may not be particularly sensitive to PRC2 deficiency but may become expressed at relatively high levels compared to other H3K27me3 target genes as a result of their ability to form mutually reinforcing transcriptional networks.
The slow, age-dependent upregulation of non-MSN-specific transcriptional regulators does not lead to an induction of other cell-or neuron-type-specific gene programs but is associated with the subsequent downregulation of MSN-specific genes. The PRC2-dependent changes in MSN gene expression, physiology and survival, while having distinct mechanistic foundations, are likely to reinforce each other, causing progressive and fatal neurodegeneration. For example, the ectopic expression of Ccnd1, which is associated with excitotoxic neuronal death, and Wt1, which is implicated in mediating neuronal degeneration in AD, can trigger cell death in neurons in vitro [27] [28] [29] . At the same time, attenuated expression of MSN-specific neurotransmitter receptors and ion channels such as Kcnd2 in PRC2-deficient MSNs can lead to pathological neuronal excitability, which may initiate secondary PRC2-independent events that promote cell death in a cell-intrinsic or cell-extrinsic fashion. The neurodegenerative process, while initially triggered by PRC2 deficiency, may progress with the help of PRC2-independent mechanisms. This scenario could preclude the identification of a single factor downstream of PRC2 that is responsible for the progression of neurodegeneration.
The progressive neurodegeneration in mice lacking PRC2 in MSNs or PCs reinforces the idea that PRC2 is involved in neurodegenerative diseases in humans. We found that the loss of PRC2 in adult forebrain neurons led to HD-like changes in gene expression ( Supplementary Figs. 3a  and 8) . Twenty to thirty percent of the PRC2 target genes that become upregulated in PRC2-deficient MSNs, including Pou4f1, Pou4fl2, Hand2, Nkx2-5, Twist1, Tal1, Wt1 and numerous Hox genes, significantly overlap with genes that are upregulated in the postmortem brains of HD patients 14, 16, 17 or mouse models of HD 46, 47 (Supplementary  Fig. 8 and Supplementary Table 7) . Like the upregulated genes, ~50% of the genes that become downregulated in PRC2 deficient MSNs (54 of 119, P < 0.001; Supplementary Table 7 ) significantly overlap with genes that are downregulated in the brains of HD patients or mouse models of the disease 46, 47 (Supplementary Fig. 4c) .
In addition to the overlap in gene expression, PRC2-deficient MSNs display alterations in MSN physiology in a fashion that resembles mouse MSNs affected by HD 48 . Like HD-affected neurons 48 , PRC2deficient MSNs display enhanced intrinsic excitability in combination with increased input resistance. Moreover, cellular alterations, including the presence of γH2ax loci and the dark cell degeneration phenotype, are reminiscent of neurodegeneration in HD in humans and in mouse models of HD 30, 31, 33 . Concurrent with the alterations in MSN-specific gene expression and function, mice with a forebrain-neuron-specific PRC2 deficiency develop progressive, fatal neurodegeneration that is similar to HD in mouse models and in humans 49 . Despite obvious phenotypic similarities between molecular, cellular and behavioral defects caused by neuronal PRC2 deficiency and neurons affected by HD, it would be naive to equate these two conditions. HD is a complex disorder in which the mutant huntingtin protein can affect various cytoplasmic as well as nuclear processes that collectively contribute to MSN degeneration. However, our data give more credence to the contribution of epigenetic mechanisms, particularly to PRC2-mediated gene expression regulation, in HD pathology and possibly in other neurodegenerative processes. The general relevance of PRC2 in neurodegenerative processes is further supported by studies that show changes in PRC2 activity and a genome-wide redistribution of H2K27me3 in the presence of ATM gene deficiency 11 and a de-repression of PRC2 target genes in a mouse model of Parkinson's disease 12 . In summary, our data reveal the importance of PRC2 in the maintenance of adult neuron specification, function and survival. Exposure to cell-extrinsic or cell-intrinsic stressors that can alter neuronal activity and/or metabolism may destabilize the neuronal subtype-specific gene expression patterns by affecting the bivalent state of non-neuronal genes or genes of other neuronal types. As discussed, changes in PRC2 function could be triggered either transiently, by nonpersisting events such as seizures 50 , or permanently, by the expression of pathogenic proteins such as mutant huntingtin protein, which can directly interfere with PRC2 recruitment and function 13, 14 . In view of our findings, the presence of the large number of self-regulatory transcription factors among PRC2 targets suggest that changes in proteins that control H3K27me3 levels or chromatin distribution globally or locally can trigger self-propagating transcriptional processes that set neurons on a path of neurodegeneration.
Altered neuron specification may interfere with coordinated function of neuronal networks and may be harmful for overall brain function. It is plausible that neurons possess an intrinsic mechanism that triggers the elimination of neurons with defective specification during development. It is tempting to speculate that the activation of PRC2controlled death-promoting genes may represent this checkpoint mechanism that enables the elimination of neurons with impaired PRC2 function. While short-term activation of such a mechanism could be beneficial for ensuring brain integrity, persistent changes in the activity or recruitment of PRC2, as well as other H3K27me3controlling enzymes, may lead to systemic neurodegeneration. a r t I C l e S METHODS Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
ONLINE METHODS
Animals. Mice were housed two to five animals per cage with a 12-h light/dark cycle (lights on from 0700 to 1900 h) at constant temperature (23 °C) with ad libitum access to food and water. All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the Icahn School of Medicine at Mount Sinai. generation of neuron-specific Ezh2 and Ezh1/Ezh2 conditional knockout and control mice. Ezh2 fl/fl mice were bred to Camk2a-cre (kindly provided by G. Schütz 51 , German Cancer Research Center, Heidelberg) or Pcp2-cre mice 52, 53 . Surgery and AAV injection. To induce deletion of Ezh2 in adult MSNs, neurotrophic adeno-associated virus (1 µl of 10 12 AAV serotype 5) expressing eGFP-Cre under the control of a CMV promoter (AAV5-cre;eGFP;Vector Biolabs) was stereotaxically injected into the dorsal striatum of Ezh1 −/− ;Ezh2 fl/fl and control mice at 10 weeks of age. The stereotactic surgery was performed as previously described 56 . The efficiency of Cre-mediated recombination was verified by immunohistochemical analysis of H3K27me3.
Purification of ex vivo cell-type-specific nuclei from mouse brain. Purification of nuclei from mouse striatum was achieved as previously described 57, 58 with minor modifications. Briefly, striata of 8 week old C57Bl/6 mice were quickly dissected and homogenized with a glass Dounce homogenizer (Kimble Chase; 1984-10002). After fixation of the cell homogenate with a final concentration of 1% formaldehyde for 8 min at room temperature (22-26 °C) and quenching of the reaction with 0.125 M glycine for 5 min at room temperature, the fixed homogenate was spun through a 29% iodixanol cushion. The resulting nuclear pellet was resuspended in resuspension buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl 2 , 20 mM tricine pH 7.8, 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor cocktail (Roche, 11836170001)) supplemented with 10 µM DyeCycle Ruby (Invitrogen, V10304), 10% donkey serum (Jackson ImmunoResearch, 017-000-121) and 1:10,000 NeuN antibody conjugated to Alexa Fluor 488 (Millipore, MAB377X). After incubation in resuspension buffer for one hour on ice, nuclei were subject to fluorescence-activated cell sorting (FACS). Two-dimensional gating criteria were used as previously described 57 . Since NeuN is a neuronal marker 59 , nuclear fractions with an Alexa Fluor 488 signal above background were considered neuronal nuclear fractions, while those with an Alexa Fluor 488 signal below background were considered glial nuclei fractions (Supplementary Fig. 2a ). After sorting, nuclei were pelleted at 2,000g for 15 min and stored at −80 °C until further analysis. chromatin immunoprecipitation (chIP). Antibodies against H3K27me3 (Millipore, 07-449), H3K27ac (Abcam, ab4729), RNA polymerase II (Abcam, ab5408) and H3K4me3 (Abcam, ab8580) were bound to Protein G magnetic beads (Diagenode, kch-818-220) for 2 h at 4 °C (50 µl Protein-G magnetic beads were incubated with 15 µg of antibody). DNA from sorted nuclei fractions (1 × 10 6 nuclei, equivalent to 10 mice each, for each ChIP) was sonicated for manufacturer's recommendation (Advanced Cell Diagnostics). After completing in situ hybridization, sections were stained with DAPI (0.2 mg/ml), imaged on a Zeiss LSM 780 confocal microscope and analyzed using Zen 2011 software. Cell counting was done using ImageJ's cell counter tool. Drd2 intensities were measured by marking the cell area and measuring the mean fluorescence intensity inside the area.
Immunofluorescence. Mice were anesthetized with ketamine (120 mg/kg) and xylazine (24 mg/kg) and perfused transcardially with 10 ml PBS and 40 ml 4% paraformaldehyde (Electron Microscopy Sciences) as previously described 62 . Fixed brains were removed and dehydrated in 5%, 15% and 30% sucrose in PBS. Following dehydration, brains were frozen in Neg-50 (Thermo Scientific) on dry ice and stored at −80 °C until further processing. Brains were cut using a cryostat and 12-to 18-µm sections were mounted on Superfrost Plus microscope slides (Fisher Scientific). Slides were stored at −80 °C until staining. Slides were washed with PBS, permeabilized with PBS + 0.2% Triton X-100 and incubated with Image-iT FX Signal Enhancer (Invitrogen) followed by blocking with 2% normal goat serum in PBS + 0.2% Triton X-100. Slides were incubated with primary antibodies ( Supplementary Table 8 ) in 2% normal goat serum in PBS + 0.2% Triton X-100 overnight at 4 °C. Slides were then washed and incubated with Alexa Fluor-conjugated secondary antibodies (Alexa Fluor 488-and 568-labeled goat anti-mouse or anti-rabbit IgGs (H+L); Supplementary Table 8 ) in 2% normal goat serum in PBS + 0.2% Triton X-100 for 1 h at room temperature. Slides were washed and coverslipped using Prolong Gold anti-fade with DAPI (Invitrogen). Image processing was performed using a Zeiss LSM 780 confocal microscope and Zen 2011 software. Immunofluorescence images were analyzed using ImageJ software. Diameters of cerebellar lobe folds were measured and analyzed in ImageJ. nissl staining. Brain sections were permeabilized in phosphate-buffered saline (PBS) with 0.1% Triton X-100 (PBS-T) for 10 min at room temperature followed by washes in PBS. Sections were incubated in NeuroTrace 530/615 (Life Technologies, cat. # N21482; 1:200 in PBS) for 20 min at room temperature and washed once with PBS-T and twice with PBS. DAPI (1:10,000 in PBS) was added for 15 min, followed by three PBS washes. Sections were mounted using Prolong Gold mounting media. electron microscopy. Mice were anesthetized with ketamine (120 mg/kg) and xylazine (24 mg/kg) and killed by intracardiac perfusion with 0.1 M sodium cacodylate buffer (pH 7.4) followed by the fixative, which contained 2.5% glutaraldehyde and 2% paraformaldehyde in the buffer. After removal from the skull, the brains were post-fixed in fresh fixative overnight at 4 °C and sliced by a vibrating blade microtome (VT100S, Leica microsystem, Buffalo Grove, IL) at 50-µm thickness. Subsequently they were post-fixed in 1% osmium tetroxide for 1 h, en bloc stained with 0.5% uranyl acetate for 30 min, dehydrated with a graded series of ethanol, and infiltrated/embedded in EMBed812 resin. A slice was prepared from striatum 0.8-0.9 mm from bregma and divided into four areas, including dorsolateral (DL), dorsomedial (DM), ventrolateral (VL) and ventromedial (VM). DL and VM areas were selected as the regions of analysis based on preliminary observations. Ultrathin sections were cut and thoroughly examined under an electron microscope (100CX JEOL, Tokyo, Japan) with a digital imaging system (XR41-C, Advantage Microscopy Technology Corp, Denver, MA).
Behavioral analysis. All behavior analyses (excluding the 24-h observation) were performed during the 0700-1900 light cycle as previously described 61, 62, 73 . For all behavioral experiments, experimenters were blinded to the genotypes of the animals. Genotypes were decoded after data was processed and analyzed. All subjects correspond to data points within two standard deviations from the sample mean and no subjects were excluded from the behavioral analyses. For all behavioral experiments, corresponding littermate control animals were used. No randomization protocol was used. Animals were allocated to treatment groups to ensure uniform distribution of ages and sexes in each group. Where two conditions are compared, a two-tailed unpaired Student's t-test was used. All procedures were conducted in strict accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the IACUC at Icahn School of Medicine at Mount Sinai.
Ontology data are available in Supplementary Tables 2, 3 and 6. All data that support the findings of this study are available from the corresponding author upon request. Statistical analyses for all experiments are detailed in the figure legends and in the Supplementary methods checklist with complete statistical details of all experiments.
